Stati Uniti INTRA-CELLULAR THERAPIES INC

68,80 -2,19% 16:03 03/05/2024 - ISIN: US46116X1019

Raccomandazioni

Giudizio Emittente Data
+ BUY CANACCORD GENUITY 23/04/2024
+ BUY BANK OF AMERICA SECURITIES 17/04/2024
+ BUY NEEDHAM 05/04/2024
- UNDERPERFORM NEEDHAM 03/04/2024
+ BUY RBC CAPITAL 03/04/2024
+ BUY RBC CAPITAL 23/02/2024